Lysosome targeted drugs: rhodamine B modified N^N-chelating ligands for half-sandwich iridium(iii) anticancer complexes

Wenli Ma, Zhenzhen Tian, Shumiao Zhang, Xiangdong He, JuanJuan Li, Xiaorong Xia, Xiaobing Chen and Zhe Liu

Inorg. Chem. Front., 2018, 5, 2587
DOI: 10.1039/C8QI00620B

Insights into the antiproliferative mechanism of (C^N)-chelated half-sandwich iridium complexes

Robin Ramos, Jérémy M. Zimbron, Serge Thorimbert, Lise-Marie Chamoreau, Annie Munier, Candice Botuha, Anthi Karaiskou, Michèle Salmain and Joëlle Sobczak-Thépot

Dalton Trans., 2020, 49, 17635
DOI: 10.1039/D0DT03414B

Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium

Chilaluck C. Konkankit, Sierra C. Marker, Kevin M. Knopf and Justin J. Wilson

Dalton Trans., 2018, 47, 9934
DOI: 10.1039/C8DT01858H

Ligand-centred redox activation of inert organoiridium anticancer catalysts

Wen-Ying Zhang, Samya Banerjee, George M. Hughes, Hannah E. Bridgewater, Ji-Inn Song, Ben G. Breeze, Guy J. Clarkson, James P. C. Coverdale, Carlos Sanchez-Cano, Fortuna Ponte, Emilia Sicilia and Peter J. Sadler

Chem. Sci., 2020, 11, 5466
DOI: 10.1039/D0SC00897D

Anticancer iridium(iii) cyclopentadienyl complexes

Pavel Štarha

Inorg. Chem. Front., 2025, 12, 897
DOI: 10.1039/D4QI02472A

Metallodrugs are unique: opportunities and challenges of discovery and development

Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, Oliver W. L. Carter, Jane M. Donnelly, Cinzia Imberti, Edward C. Lant, Frederik Lermyte, Russell J. Needham, Marta Palau, Peter J. Sadler, Huayun Shi, Fang-Xin Wang, Wen-Ying Zhang and Zijin Zhang

Chem. Sci., 2020, 11, 12888
DOI: 10.1039/D0SC04082G

A comprehensive survey of cytotoxic active half-sandwich Ir(iii) complexes: structural perspective, and mechanism of action

Ahmed M. Mansour, Mohamed M. Arafa, Yara S. Hegazy, Muhammed S. Sadek, Hadeer H. Ibrahim, Yomna S. Abdullah and Ola R. Shehab

Dalton Trans., 2025, 54, 4788
DOI: 10.1039/D4DT03219E

Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cells

Samuel M. Meier-Menches, Katja Zappe, Andrea Bileck, Dominique Kreutz, Ammar Tahir, Margit Cichna-Markl and Christopher Gerner

Metallomics, 2019, 11, 118
DOI: 10.1039/C8MT00152A

Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents

Ana C. Carrasco, Vanessa Rodríguez-Fanjul, Abraha Habtemariam and Ana M. Pizarro

J. Med. Chem., 2020, 63, 4005
DOI: 10.1021/acs.jmedchem.9b02000

Cytotoxic Organometallic Iridium(III) Complexes

Irena Kostova

Molecules, 2025, 30, 801
DOI: 10.3390/molecules30040801

A Half-Sandwich Os(II) Glucoconjugated NHC Complex as a Modulator of Amyloid Aggregation

Daniele Florio, Alfonso Annunziata, Valeria Panzetta, Paolo A. Netti, Francesco Ruffo and Daniela Marasco

Inorg. Chem., 2025, 64, 3335
DOI: 10.1021/acs.inorgchem.4c04823

Different behaviors of self-assembled nanostructure with three-types of azopyridine hydrochloride salts

Bin Wang and Haoran Qian

Mater. Res. Express, 2019, 6, 045104
DOI: 10.1088/2053-1591/aafe56

Antitumor Effects of Ir(III)-2H-Indazole Complexes for Triple Negative Breast Cancer

Rajeeva Lochana Panchangam, Ramdas Nishanth Rao, Musuvathi Motilal Balamurali, Tejashri B. Hingamire, Dhanasekaran Shanmugam, Venkatraman Manickam and Kaushik Chanda

Inorg. Chem., 2021, 60, 17593
DOI: 10.1021/acs.inorgchem.1c02193

Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer

Nazia Nayeem and Maria Contel

Chemistry A European J, 2021, 27, 8891
DOI: 10.1002/chem.202100438

Effects of structurally varied fluorescent half-sandwich iridium(III) Schiff base complexes on A549 cell line

Xicheng Liu, Changjian Ji, Rui Tao, Wenya Zheng, Mengxian Liu, Shiqing Bi, Qinghua Chang, Xiang-Ai Yuan, Mingbo Yue and Zhe Liu

Journal of Inorganic Biochemistry, 2025, 263, 112792
DOI: 10.1016/j.jinorgbio.2024.112792

Design, synthesis, and evaluation of fluorine and Naphthyridine–Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity

JuanJuan Li, Zhenzhen Tian, Xingxing Ge, Zhishan Xu, Yaqian Feng and Zhe Liu

European Journal of Medicinal Chemistry, 2019, 163, 830
DOI: 10.1016/j.ejmech.2018.12.021

Half-Sandwich Ir(III) Complex of N1-Pyridyl-7-azaindole Exceeds Cytotoxicity of Cisplatin at Various Human Cancer Cells and 3D Multicellular Tumor Spheroids

Pavel Štarha, Zdeněk Trávníček, Hana Crlíková, Ján Vančo, Jana Kašpárková and Zdeněk Dvořák

Organometallics, 2018, 37, 2749
DOI: 10.1021/acs.organomet.8b00415

Oxidative Stress in Cancer Therapy: Friend or Enemy?

Maria Azmanova and Anaïs Pitto‐Barry

ChemBioChem, 2022, 23
DOI: 10.1002/cbic.202100641

Cytotoxic Activity of Some Half‐sandwich Rhodium(III) Complexes Containing 4,4’‐disubstituted‐2,2’‐bipyridine Ligands

Marion Graf, Jasmine Ochs, Peter Mayer, Nils Metzler‐Nolte and Hans‐Christian Böttcher

Zeitschrift anorg allge chemie, 2024, 650
DOI: 10.1002/zaac.202300195

Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy

Sourav De, Sabnaz Kazi, Sabyasachi Banerjee, Subhasis Banerjee, Nandan Sarkar, Suraj Kumar Shah, Yung-Chih Kuo and S.K. Ashok Kumar

Coordination Chemistry Reviews, 2024, 498, 215462
DOI: 10.1016/j.ccr.2023.215462

Organometallic Iridium Arene Compounds: The Effects ofC-Donor Ligands on Anticancer Activity

Rianne M. Lord and Patrick C. McGowan

Chem. Lett., 2019, 48, 916
DOI: 10.1246/cl.190179

Synthesis, crystal structure and Hirshfeld surface analysis of [bis(diphenylphosphanyl)methane-κP]chloridobis[2-(pyridin-2-yl)phenyl-κ2N,C1]iridium(III)

Ekkapong Klaimanee, Peerapong Sangwisut, Saowanit Saithong and Nararak Leesakul

Acta Crystallogr E Cryst Commun, 2021, 77, 217
DOI: 10.1107/S2056989021000955

Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X‐Ray Imaging

José Javier Conesa, Ana C. Carrasco, Vanessa Rodríguez‐Fanjul, Yang Yang, José L. Carrascosa, Peter Cloetens, Eva Pereiro and Ana M. Pizarro

Angew Chem Int Ed, 2020, 59, 1270
DOI: 10.1002/anie.201911510

Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals

Binoy Kar, Nilmadhab Roy, Sudhindra Pete, Prithvi Moharana and Priyankar Paira

Inorganica Chimica Acta, 2020, 512, 119858
DOI: 10.1016/j.ica.2020.119858

Cytotoxicity, anti-tumor effects and structure-activity relationships of nickel and palladium S,C,S pincer complexes against double and triple-positive and triple-negative breast cancer (TNBC) cells

Mahboubeh Hosseini-Kharat, Rahmatollah Rahimi, Ali Mohammad Alizadeh, Davit Zargarian, Solmaz Khalighfard, Loïc P. Mangin, Nasim Mahigir, Seyed Hasan Ayati and Amir Abbas Momtazi-Borojeni

Bioorganic & Medicinal Chemistry Letters, 2021, 43, 128107
DOI: 10.1016/j.bmcl.2021.128107

Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment

Cheng Peng, Chaoqun You, Shuang Cao, Linfei Cheng, Jiaji Ren, Jiashi Cao, Jing Wang, Tielong Liu and Makoto Endo

Analytical Cellular Pathology, 2025, 2025
DOI: 10.1155/ancp/6517238

Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X‐Ray Imaging

José Javier Conesa, Ana C. Carrasco, Vanessa Rodríguez‐Fanjul, Yang Yang, José L. Carrascosa, Peter Cloetens, Eva Pereiro and Ana M. Pizarro

Angewandte Chemie, 2020, 132, 1286
DOI: 10.1002/ange.201911510

Structure-activity relationships for osmium(II) arene phenylazopyridine anticancer complexes functionalised with alkoxy and glycolic substituents

Russell J. Needham, Hannah E. Bridgewater, Isolda Romero-Canelón, Abraha Habtemariam, Guy J. Clarkson and Peter J. Sadler

Journal of Inorganic Biochemistry, 2020, 210, 111154
DOI: 10.1016/j.jinorgbio.2020.111154

Endocytic Uptake of Self‐Assembled Iridium(III) Nanoaggregates for Holistic Treatment of Metastatic 3D Triple‐Negative Breast Tumor Spheroids

Ayushi Chaudhary, Ashwini Kumar, Nikhil Swain, Kajal Chaudhary, Himanshu Sonker, Sayari Dewan, Rutwik Anil Patil and Ritika Gautam Singh

Small, 2025, 21
DOI: 10.1002/smll.202406809

Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents

Eva Domínguez-Martís, Diego Mosteiro-Miguéns, Lucía Vigo-Gendre, David López-Ares, Manuel Freire-Garabal, María Núñez-Iglesias and Silvia Novío

Crystals, 2018, 8, 369
DOI: 10.3390/cryst8100369

Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics

Kristine Laws, Arvin Eskandari, Chunxin Lu and Kogularamanan Suntharalingam

Chemistry A European J, 2018, 24, 15205
DOI: 10.1002/chem.201803521

Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation

Benjamin F. Hohlfeld, Burkhard Gitter, Christopher J. Kingsbury, Keith J. Flanagan, Dorika Steen, Gerhard D. Wieland, Nora Kulak, Mathias O. Senge and Arno Wiehe

Chemistry A European J, 2021, 27, 6440
DOI: 10.1002/chem.202004776

Identification of Cellular Protein Targets of a Half-Sandwich Iridium(III) Complex Reveals Its Dual Mechanism of Action via Both Electrophilic and Oxidative Stresses

Robin Ramos, Anthi Karaiskou, Candice Botuha, Sadek Amhaz, Michaël Trichet, Florent Dingli, Jérémy Forté, France Lam, Alexis Canette, Chloé Chaumeton, Murielle Salome, Thomas Chenuel, Céline Bergonzi, Philippe Meyer, Sylvain Bohic, Damarys Loew, Michèle Salmain and Joëlle Sobczak-Thépot

J. Med. Chem., 2024, 67, 6189
DOI: 10.1021/acs.jmedchem.3c02000

Bioorthogonal Postlabeling Reveals Nuclear Localization of a Highly Cytotoxic Half‐Sandwich Ir(III) Tetrazine Complex in Live Cells

Alfonso Annunziata, Sadek Amhaz, Jérémy Forté, Geoffrey Gontard, Romain Morichon, Joëlle Sobczak‐Thépot and Michèle Salmain

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202500090

Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies

JuanJuan Li, Lihua Guo, Zhenzhen Tian, Shumiao Zhang, Zhishan Xu, Yali Han, Ruixia Li, Yan Li and Zhe Liu

Inorg. Chem., 2018, 57, 13552
DOI: 10.1021/acs.inorgchem.8b02161

Advanced technological tools to study multidrug resistance in cancer

Luca Andrei, Sandor Kasas, Ignacio Ochoa Garrido, Tijana Stanković, Mónica Suárez Korsnes, Radka Vaclavikova, Yehuda G. Assaraf and Milica Pešić

Drug Resistance Updates, 2020, 48, 100658
DOI: 10.1016/j.drup.2019.100658

Cytotoxic Activities of Half‐sandwich M(III) Complexes (M=Rh, Ir) Bearing Chloro‐substituted Bidentate‐coordinated Phenanthroline or Terpyridine Ligands

Marion Graf, Jasmine Ochs, Nils Metzler‐Nolte, Hans‐Christian Böttcher and Peter Mayer

Zeitschrift anorg allge chemie, 2023, 649
DOI: 10.1002/zaac.202300082

Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes

Anne Vessières, Emie Quissac, Nolwenn Lemaire, Agusti Alentorn, Patrycja Domeracka, Pascal Pigeon, Marc Sanson, Ahmed Idbaih and Maïté Verreault

IJMS, 2021, 22, 10404
DOI: 10.3390/ijms221910404

Cytotoxic BODIPY-Appended Half-Sandwich Iridium(III) Complex Forms Protein Adducts and Induces ER Stress

Robin Ramos, Jean-François Gilles, Romain Morichon, Cédric Przybylski, Benoît Caron, Candice Botuha, Anthi Karaiskou, Michèle Salmain and Joëlle Sobczak-Thépot

J. Med. Chem., 2021, 64, 16675
DOI: 10.1021/acs.jmedchem.1c01335

Synthesis, Characterization and Cytotoxic Activities of Half‐sandwich Pentamethylcyclopentadienyl Iridium(III) Complexes Containing 4,4'‐substituted 2,2'‐Bipyridine Ligands

Marion Graf, Jasmine Ochs, Nils Metzler‐Nolte, Peter Mayer and Hans‐Christian Böttcher

Zeitschrift anorg allge chemie, 2023, 649
DOI: 10.1002/zaac.202200382

Spectroscopic and electrochemical study for evaluating DNA interaction activity of 4‐(3‐halophenyl)‐6‐(pyridin‐2‐yl)pyrimidin‐2‐amine based piano stool Cp* Rh (III) and Ir (III) complexes

Pankajkumar A. Vekariya, Parag S. Karia, Bhupesh S. Bhatt and Mohan N. Patel

Applied Organom Chemis, 2019, 33
DOI: 10.1002/aoc.5152